These medicines have undergone rigorous clinical evaluation, have approved SmPCs, and are prescribed with appropriate monitoring and follow-up
The risk of cardiovascular events such as heart attack and stroke was also 18 per cent lower for those on semaglutide, which was given to half of the participants in the placebo-controlled trial, while risk of death from any cause was 20 per cent lower, says the study findings published in The New England Journal of Medicine today
While your knee-jerk reaction may be to lower your homocysteine, the right dietary and lifestyle adjustments can optimize homocysteine levels for better well-being
Final Note for NZ Patients Switching weight-loss medications should be structured, safe, and medically supervised
While studies confirm their potential, they have very different track records